Fulgent Genetics (FLGT) Total Liabilities (2015 - 2026)

Fulgent Genetics has disclosed Total Liabilities across 12 years of filings, most recently posting $112.2 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $112.2 million, up 35.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.2 million (up 35.24% YoY), and the FY2025 annual result was $106.8 million, up 17.63% from the prior year.
• Total Liabilities came in at $112.2 million for Q1 2026 at Fulgent Genetics, up from $106.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $152.6 million in Q1 2022 to a low of $83.0 million in Q1 2025.
• The 5-year median for Total Liabilities is $103.2 million (2024), against an average of $107.2 million.
• Across the five-year window, Total Liabilities plunged 39.54% in 2023 and soared 35.24% in 2026, its largest moves.
• Fulgent Genetics' Total Liabilities stood at $116.2 million in 2022, then slipped by 12.17% to $102.0 million in 2023, then fell by 11.01% to $90.8 million in 2024, then advanced by 17.63% to $106.8 million in 2025, then rose by 5.06% to $112.2 million in 2026.
• The last three Total Liabilities figures came in at $112.2 million (Q1 2026), $106.8 million (Q4 2025), and $93.8 million (Q3 2025), per Business Quant data.